Endothelium-derived NO, but not cyclic GMP, is required for hypoxic augmentation in isolated porcine coronary arteries

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 301, Issue 6, 2011, Pages 2313-2321

  Chan, Calvin K Y ^a   Mak, Judith ^a,b   Gao, Yuansheung ^c   Man, Ricky Y K ^a   Vanhoutte, Paul M ^a,d  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^d Chonbuk National University   (South Korea)

Author keywords

Calcium sensitization; Nitric oxide; Soluble guanylyl cyclase

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 8 BROMO CYCLIC GMP; ATRIAL NATRIURETIC FACTOR; CALCIUM; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FASUDIL; GUANYLATE CYCLASE; GUANYLATE CYCLASE INHIBITOR; ISOPRENALINE; N(G) NITROARGININE METHYL ESTER; NIFEDIPINE; NITRIC OXIDE; THAPSIGARGIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY CONSTRICTION; ENDOTHELIUM; FLUORESCENCE MICROSCOPY; HYPOXIA; ISOMETRICS; NONHUMAN; PRIORITY JOURNAL; VASOCONSTRICTION;

ANIMALS; ANOXIA; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CORONARY VESSELS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; GUANYLATE CYCLASE; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE TYPE III; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RHO-ASSOCIATED KINASES; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SWINE; VASOCONSTRICTION;

EID: 82855169297     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00258.2011     Document Type: Article

References (66)

1. Adachi T, Weisbrod RM, Pimentel DR, Ying J, Sharov VS, Schoneich C, Cohen RA. S-glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat Med 10: 1200-1207, 2004.
2. Auch-Schwelk W, Katusic ZS, Vanhoutte PM. Contractions to oxygenderived free radicals are augmented in aorta of the spontaneously hypertensive rat. Hypertension 13: 859-864, 1989.
3. Auch-Schwelk W, Vanhoutte PM. Endothelium-derived relaxing factor(s) and calcium antagonists. Z Kardiol 78, Suppl 6: 120-123, 1989.
4. Benigni A, Remuzzi G. Endothelin antagonists. Lancet 353: 133-138, 1999.
5. Boullerne AI, Nedelkoska L, Benjamins JA. Role of calcium in nitric oxide-induced cytotoxicity: EGTA protects mouse oligodendrocytes. J Neurosci Res 63: 124-135, 2001.
6. Braumann T, Erneux C, Petridis G, Stohrer WD, Jastorff B. Hydrolysis of cyclic nucleotides by a purified cGMP-stimulated phosphodiesterase: structural requirements for hydrolysis. Biochim Biophys Acta 871: 199-206, 1986.
7. Chan CK, Mak JC, Man RY, Vanhoutte PM. Rho kinase inhibitors prevent endothelium-dependent contractions in the rat aorta. J Pharmacol Exp Ther 329: 820-826, 2009.
8. Cognard C, Rivet M, Raymond G. The blockade of excitation/contraction coupling by nifedipine in patch-clamped rat skeletal muscle cells in culture. Pflügers Arch 416: 98-105, 1990.
9. Das S, Kumar KN. Nitric oxide: its identity and role in blood pressure control. Life Sci 57: 1547-1556, 1995.
10. De Mey JG, Vanhoutte PM. Anoxia and endothelium-dependent reactivity of the canine femoral artery. J Physiol 335: 65-74, 1983.
11. De Mey JG, Vanhoutte PM. Contribution of the endothelium to the response to anoxia in the canine femoral artery. Arch Int Pharmacodyn Ther 253: 325-326, 1981.
12. Dettmann ES, Luscher TF, Flammer J, Haefliger IO. Modulation of endothelin-1-induced contractions by magnesium/calcium in porcine ciliary arteries. Graefes Arch Clin Exp Ophthalmol 236: 47-51, 1998.
13. Duprez DA, Essandoh LK, Vanhoutte PM, Shepherd JT. Vascular responses in forearm and calf to contralateral static exercises. J Appl Physiol 66: 669-674, 1989.
14. Eder U, Fischer-Colbrie R, Kogner P, Leitner B, Bjellerup P, Winkler H. Levels and molecular forms of chromogranins in human childhood neuroblastomas and ganglioneuromas. Neurosci Lett 253: 17-20, 1998.
15. Evgenov OV, Pacher P, Schmidt PM, Hasko G, Schmidt HH, Stasch JP. NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential. Nat Rev Drug Discov 5: 755-768, 2006.
16. Feletou M, Vanhoutte PM. Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol 291: H985-H1002, 2006.
17. Feletou M, Vanhoutte PM. Endothelium-derived hyperpolarizing factor: where are we now? Arterioscler Thromb Vasc Biol 26: 1215-1225, 2006.
18. Félétou M, Vanhoutte PM. EDHF: the Complete Story. Boca Raton, FL: CRC/Taylor & Francis Group, 2006, p. 298 p.
19. Fischer-Colbrie R, Kirchmair R, Kahler CM, Wiedermann CJ, Saria A. Secretoneurin: a new player in angiogenesis and chemotaxis linking nerves, blood vessels and the immune system. Curr Protein Pept Sci 6: 373-385, 2005.
20. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 3: 2007-2018, 1989.
21. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
22. Graeser T, Vanhoutte PM. Hypoxic contraction of canine coronary arteries: role of endothelium and cGMP. Am J Physiol Heart Circ Physiol 261: H1769-H1777, 1991.
23. Gruber B, Schratzberger P, Kahler CM, Dunzendorfer S, Bellmann R, Reinisch N, Wiedermann CJ. Staurosporine-dependent activation of human endothelial cell monolayers for neutrophil adherence by secretoneurin. Peptides 18: 1445-1447, 1997.
24. Hidaka H, Inagaki M, Kawamoto S, Sasaki Y. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23: 5036-5041, 1984.
25. 2+ sensitization of the contractile apparatus in vascular smooth muscle. J Pharm Sci 104: 109-115, 2007.
26. Hoeffner U, Feletou M, Flavahan NA, Vanhoutte PM. Canine arteries release two different endothelium-derived relaxing factors. Am J Physiol Heart Circ Physiol 257: H330-H333, 1989.
27. Hoshino Y, Morrison KJ, Vanhoutte PM. Mechanisms of hypoxic vasoconstriction in the canine isolated pulmonary artery: role of endothelium and sodium pump. Am J Physiol Lung Cell Mol Physiol 267: L120-L127, 1994.
28. Iqbal A, Vanhoutte PM. Flunarizine inhibits endothelium-dependent hypoxic facilitation in canine coronary arteries through an action on vascular smooth muscle. Br J Pharmacol 95: 789-794, 1988.
29. Jankowski V, Tolle M, Vanholder R, Schonfelder G, van der Giet M, Henning L, Schluter H, Paul M, Zidek W, Jankowski J. Uridine adenosine tetraphosphate: a novel endothelium- derived vasoconstrictive factor. Nat Med 11: 223-227, 2005.
30. Keung W, Vanhoutte PM, Man RY. Acute impairment of contractile responses by 17beta-estradiol is cAMP and protein kinase G dependent in vascular smooth muscle cells of the porcine coronary arteries. Br J Pharmacol 144: 71-79, 2005.
31. Komori K, Shimokawa H, Vanhoutte PM. Endothelium-dependent relaxation in response to aggregating platelets in porcine femoral veins and its modulation by diet. Circulation 80: 401-409, 1989.
32. 2+]i. Br J Pharmacol 147: 55-63, 2006.
33. Liang CF, Au AL, Leung SW, Ng KF, Feletou M, Kwan YW, Man RY, Vanhoutte PM. Endothelium-derived nitric oxide inhibits the relaxation of the porcine coronary artery to natriuretic peptides by desensitizing big conductance calcium-activated potassium channels of vascular smooth muscle. J Pharmacol Exp Ther 334: 223-231, 2010.
34. Lincoln TM, Dey N, Sellak H. Invited review: cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression. J Appl Physiol 91: 1421-1430, 2001.
35. Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S, Chepenik KP, Waldman SA. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 52: 375-414, 2000.
36. Michel T, Vanhoutte PM. Cellular signaling and NO production. Pflügers Arch 459: 807-816. 2010.
37. Moncada S, Vane JR. Prostacyclin and its clinical applications. Ann Clin Res 16: 241-252, 1984.
38. Munzel T, Heitzer T, Harrison DG. The physiology and pathophysiology of the nitric oxide/superoxide system. Herz 22: 158-172, 1997.
39. Olesen SP, Drejer J, Axelsson O, Moldt P, Bang L, Nielsen-Kudsk JE, Busse R, Mulsch A. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase. Br J Pharmacol 123: 299-309, 1998.
40. Pal B, Kitagawa T. Binding of YC-1/BAY 41-2272 to soluble guanylate cyclase: A new perspective to the mechanism of activation. Biochem Biophys Res Commun 397: 375-379, 2010.
41. Pearson PJ, Lin PJ, Schaff HV, Vanhoutte PM. Augmented endothelium- dependent constriction to hypoxia early and late following reperfusion of the canine coronary artery. Clin Exp Pharmacol Physiol 23: 634-641, 1996.
42. Qi H, Zheng X, Qin X, Dou D, Xu H, Raj JU, Gao Y. Protein kinase G regulates the basal tension and plays a major role in nitrovasodilatorinduced relaxation of porcine coronary veins. Br J Pharmacol 152: 1060-1069, 2007.
43. Qin X, Zheng X, Qi H, Dou D, Raj JU, Gao Y. CGMP-dependent protein kinase in regulation of basal tone and in nitroglycerin- and nitric-oxideinduced relaxation in porcine coronary artery. Pflügers Arch 454: 913-923, 2007.
44. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 50: 413-492, 1998.
45. Rubanyi GM, Vanhoutte PM. Hypoxia releases a vasoconstrictor substance from the canine vascular endothelium. J Physiol 364: 45-56, 1985.
46. Schini VB, Hendrickson H, Heublein DM, Burnett JC Jr, Vanhoutte PM. Thrombin enhances the release of endothelin from cultured porcine aortic endothelial cells. Eur J Pharmacol 165: 333-334, 1989.
47. Schmid KW, Schroder S, Dockhorn-Dworniczak B, Kirchmair R, Totsch M, Bocker W, Fischer-Colbrie R. Immunohistochemical demonstration of chromogranin A, chromogranin B, and secretogranin II in extra-adrenal paragangliomas. Mod Pathol 7: 347-353, 1994.
48. Shibano T, Codina J, Birnbaumer L, Vanhoutte PM. Pertussis toxinsensitive G proteins in regenerated endothelial cells of porcine coronary artery. Am J Physiol Heart Circ Physiol 267: H979-H981, 1994.
49. Shimokawa H, Vanhoutte PM. Dietary omega 3 fatty acids and endothelium- dependent relaxations in porcine coronary arteries. Am J Physiol Heart Circ Physiol 256: H968-H973, 1989.
50. Shimokawa H, Vanhoutte PM. Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis. Circ Res 64: 900-914, 1989.
51. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83: 1325-1358, 2003.
52. -/- knockout mice. J Cardiovasc Pharmacol 46: 761-765, 2005.
53. Tang EH, Leung FP, Huang Y, Feletou M, So KF, Man RY, Vanhoutte PM. Calcium and reactive oxygen species increase in endothelial cells in response to releasers of endothelium-derived contracting factor. Br J Pharmacol 151: 15-23, 2007.
54. Tang EH, Vanhoutte PM. Prostanoids and reactive oxygen species: team players in endothelium-dependent contractions. Pharmacol Ther 122: 140-149, 2009.
55. ten Freyhaus H, Huntgeburth M, Wingler K, Schnitker J, Baumer AT, Vantler M, Bekhite MM, Wartenberg M, Sauer H, Rosenkranz S. Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation. Cardiovasc Res 71: 331-341, 2006.
56. Thorne GD, Hilliard GM, Paul RJ. Vascular oxygen sensing: detection of novel candidates by proteomics and organ culture. J Appl Physiol 96: 802-808; discussion 792, 2004.
57. 2+-independent mechanisms. Cell Calcium 36: 201-208, 2004.
58. Vanhoutte PM. Epithelium-derived relaxing factor(s) and bronchial reactivity. J Allergy Clin Immunol 83: 855-861, 1989.
59. Vanhoutte PM, Auch-Schwelk W, Boulanger C, Janssen PA, Katusic ZS, Komori K, Miller VM, Schini VB, Vidal M. Does endothelin-1 mediate endothelium-dependent contractions during anoxia? J Cardiovasc Pharm 13, Suppl 5: S124-128; discussion S142, 1989.
60. Walia M, Samson SE, Schmidt T, Best K, Whittington M, Kwan CY, Grover AK. Peroxynitrite and nitric oxide differ in their effects on pig coronary artery smooth muscle. Am J Physiol Cell Physiol 284: C649-C657, 2003.
61. Wu W, Platoshyn O, Firth AL, Yuan JX. Hypoxia divergently regulates production of reactive oxygen species in human pulmonary and coronary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 293: L952-L959, 2007.
62. 2+ channels. J Hypertens Suppl 6: S188-191, 1988.
63. Zhao E, Basak A, Wong AO, Ko W, Chen A, Lopez GC, Grey CL, Canosa LF, Somoza GM, Chang JP, Trudeau VL. The secretogranin II-derived peptide secretoneurin stimulates luteinizing hormone secretion from gonadotrophs. Endocrinology 150: 2273-2282, 2009.
64. Zhao E, Zhang D, Basak A, Trudeau VL. New insights into graninderived peptides: evolution and endocrine roles. Gen Comp Endocrinol 164: 161-174, 2009.
65. Zhao Y, Brandish PE, DiValentin M, Schelvis JP, Babcock GT, Marletta MA. Inhibition of soluble guanylate cyclase by ODQ. Biochemistry 39: 10848-10854, 2000.
66. Zoccali C, Catalano C, Rastelli S. Blood pressure control: hydrogen sulfide, a new gasotransmitter, takes stage. Nephrol Dial Transplant 24: 1394-1396, 2009.